T cell epitopes of the hepatitis B virus nucleocapsid protein

Drug – bio-affecting and body treating compositions – Lymphokine

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

424 89, 530324, 530325, 530326, 530327, 530350, 530403, 530806, 530807, A61K 3900, A61K 3929, C07K 700, C07K 1500

Patent

active

048821454

ABSTRACT:
Polypeptides corresponding in amino acid residue sequence to T cell stimulating regions of the HBV nucleocapsid protein are disclosed. A method of enhancing the immunogenicity of a polypeptide immunogen comprising operatively linking the polypeptide through an amino acid residue side chain to core protein particles is also disclosed.

REFERENCES:
patent: 4474757 (1984-10-01), Arnon et al.
patent: 4584195 (1986-04-01), Schoolnik et al.
patent: 4663436 (1987-05-01), Elder et al.
patent: 4683136 (1987-07-01), Milich et al.
Bittle et al., Nature, 298; pp. 30-33 (1982).
Valenzuela et al., Bio/Technology, 3, pp. 323-326 (1985).
Wian-Hobson et al., Cell, 40, pp. 9-17 (1985).
Milich et al., Science, vol. 234, pp. 1398-1401 (12/12/86).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

T cell epitopes of the hepatitis B virus nucleocapsid protein does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with T cell epitopes of the hepatitis B virus nucleocapsid protein, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and T cell epitopes of the hepatitis B virus nucleocapsid protein will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1424980

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.